Mesoblast Limited
MESONASDAQHealthcare● Active
$13.78
$-0.17(-1.21%)
Market Cap$1.8B
P/E Ratio—
52W High$21.5
52W Low$9.88
Mesoblast Limited (MESO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MESO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $17.20M | $5.90M | $7.50M | $10.21M | $7.46M |
| Cost of Revenue | $5.13M | $41.07M | $54.92M | $63.57M | $85.73M |
| Gross Profit | $12.07M | ($35.17M) | ($47.42M) | ($53.36M) | ($78.28M) |
| Gross Margin %(computed) | 70.17% | -595.87% | -632.20% | -522.58% | — |
| Operating Expenses | |||||
| R&D Expenses | $34.81M | $25.35M | $27.19M | $32.81M | $53.01M |
| G&A Expenses | $23.21M | $23.63M | $25.37M | $27.21M | $30.87M |
| Total Operating Expenses | $74.51M | $48.98M | $76.79M | $90.78M | $115.06M |
| Operating Income | ($62.44M) | ($84.15M) | ($69.29M) | ($80.57M) | ($109.10M) |
| Operating Margin %(computed) | -363.08% | — | -923.73% | -789.09% | — |
| Interest Income | $3.55M | $1.82M | $0.83M | $0.00M | $0.00M |
| Interest Expense | $22.93M | $20.66M | $19.44M | $17.29M | $10.71M |
| Income Before Tax | ($101.81M) | ($88.15M) | ($82.10M) | ($91.59M) | ($99.63M) |
| Income Tax Expense | $0.33M | ($0.19M) | ($0.21M) | ($0.24M) | ($0.82M) |
| Net Income | ($102.14M) | ($87.96M) | ($81.89M) | ($91.35M) | ($98.81M) |
| Net Margin %(computed) | -593.92% | — | — | -894.59% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.84 | $-0.89 | $-0.98 | $-1.30 | $-1.60 |
| Wtd Avg Shares | 120.78M | 98.67M | 83.77M | 68.27M | 60.51M |
| EBITDA | ($73.66M) | ($56.08M) | ($58.55M) | ($76.57M) | ($84.65M) |
| EBITDA Margin %(computed) | -428.30% | -950.14% | -780.56% | -749.91% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Mesoblast Limited data
About Mesoblast Limited (MESO) Income Statement
Mesoblast Limited (MESO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MESO reported revenue of $0.02B, gross profit of $0.01B (gross margin 70.17%), and net income of ($0.10B) — a net profit margin of -593.92%.
Frequently asked questions
MESO · 4 questionsMesoblast Limited (MESO) reported revenue of $0.02B for 2025, up 191.4% year-over-year.
MESO revenueMESO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08